Antidote Health Raises $22 Million In Series A Funding
03/22/22, 6:00 AM
Money raised
$22 million
Round Type
series a
As a leading telehealth provider offering quality, affordable healthcare to tens of millions of households across the United States, Antidote Health today announced the completion of a $22 million Series A funding round. This was led by third-time investor iAngels, Group 11, and Flint Capital. With the investment and the prior $12 million seed funding, the platform aims to deepen its market presence and expand its services nationwide. The funds will also support R&D activity, which includes advanced AI screening and clinical decision support system capabilities.
Company Info
Additional Info
Antidote Health, a leading telehealth company, believes healthcare is a fundamental human right. Our services democratize access, delivering care for the whole family for a single price. We work with businesses of any size, non-profits and individuals. Our goal is to ensure that everyone can have affordable, high-quality acute, primary and chronic care services, 24/7/365. Antidote Health is available to more than 60 percent of the U.S. population. For more information and to see what our users think, visit: www.antidotehealth.ai